Mirae Asset Global Investments increased its stake in Intuit (INTU) by 3.85% based on its latest 2019Q1 regulatory filing with the SEC. Mirae Asset Global Investments bought 5,210 shares as the company’s stock rose 13.72% . The institutional investor held 140,687 shares of the prepackaged software company at the end of 2019Q1, valued at $36.74M, up from 135,477 at the end of the previous reported quarter. Mirae Asset Global Investments who had been investing in Intuit for a number of months, seems to be bullish on the $74.05B market cap company. The stock increased 1.77% or $5 during the last trading session, reaching $286.94. About 1.10 million shares traded. Intuit Inc. (NASDAQ:INTU) has risen 36.82% since August 30, 2018 and is uptrending. It has outperformed by 36.82% the S&P500. Some Historical INTU News: 22/05/2018 – INTUIT SEES 4Q ADJ EPS 22C TO 24C, EST. 21C; 22/05/2018 – INTUIT 3Q NET REV. $2.93B, EST. $2.86B; 22/05/2018 – Intuit 3Q Rev $2.93B; 22/05/2018 – Intuit Sees 4Q EPS 4c-EPS 6c; 25/04/2018 – INTUIT REPORTS 6% BOOST IN TURBOTAX ONLINE UNITS:; 22/05/2018 – Intuit Raises FY View To Rev $5.915B-$5.935B; 02/04/2018 – Fidelity Advisor Tech Adds Intuit, Exits Wex, Cuts Facebook; 07/03/2018 – Medfusion Launches its Newest Patient Experience Platform at HIMSS18
Alps Advisors Inc decreased its stake in Chemocentryx Inc (CCXI) by 22.05% based on its latest 2019Q1 regulatory filing with the SEC. Alps Advisors Inc sold 34,520 shares as the company’s stock declined 38.33% . The institutional investor held 122,039 shares of the health care company at the end of 2019Q1, valued at $1.70 million, down from 156,559 at the end of the previous reported quarter. Alps Advisors Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $393.77M market cap company. The stock increased 0.15% or $0.01 during the last trading session, reaching $6.76. About 287,842 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has declined 28.17% since August 30, 2018 and is downtrending. It has underperformed by 28.17% the S&P500. Some Historical CCXI News: 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 09/03/2018 ChemoCentryx 4Q EPS 80c; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress
More notable recent Intuit Inc. (NASDAQ:INTU) news were published by: Seekingalpha.com which released: “Intuit +3.1% as analysts boost targets after beat – Seeking Alpha” on August 23, 2019, also Seekingalpha.com with their article: “Intuit Pushes AI To Simplify Tax Filing – Seeking Alpha” published on August 29, 2019, Finance.Yahoo.com published: “Stocks – Wall Street Plunges as Trumps Tells US Companies to Leave China – Yahoo Finance” on August 23, 2019. More interesting news about Intuit Inc. (NASDAQ:INTU) were released by: Finance.Yahoo.com and their article: “Is Intuit Inc. (INTU) A Good Stock To Buy? – Yahoo Finance” published on June 10, 2019 as well as Nasdaq.com‘s news article titled: “3 Reasons Why Intuit (INTU) Is a Great Growth Stock – Nasdaq” with publication date: April 04, 2019.
Investors sentiment increased to 1.02 in Q1 2019. Its up 0.04, from 0.98 in 2018Q4. It increased, as 37 investors sold INTU shares while 275 reduced holdings. 99 funds opened positions while 219 raised stakes. 221.14 million shares or 7.15% less from 238.18 million shares in 2018Q4 were reported. Brown Brothers Harriman owns 0.01% invested in Intuit Inc. (NASDAQ:INTU) for 4,826 shares. Veritable Ltd Partnership reported 7,722 shares. Conning invested 0.05% in Intuit Inc. (NASDAQ:INTU). Arrowstreet Cap Ltd Partnership stated it has 0.86% in Intuit Inc. (NASDAQ:INTU). Fort LP holds 10,520 shares. Thomas White Int Limited stated it has 6,760 shares. Neville Rodie & Shaw owns 0.03% invested in Intuit Inc. (NASDAQ:INTU) for 1,083 shares. First Hawaiian Natl Bank owns 0.22% invested in Intuit Inc. (NASDAQ:INTU) for 15,981 shares. Long Road Inv Counsel Lc stated it has 10,000 shares. Cleararc owns 6,302 shares. Mackay Shields Limited Liability Corp owns 55,010 shares. 8,251 were reported by Oppenheimer Com Incorporated. Sandy Spring State Bank, a Maryland-based fund reported 738 shares. Pitcairn owns 21,511 shares. Troy Asset Mngmt Limited reported 53,482 shares stake.
Mirae Asset Global Investments, which manages about $4.74B and $13.69B US Long portfolio, decreased its stake in Bank Amer Corp (NYSE:BAC) by 221,338 shares to 448,657 shares, valued at $12.34M in 2019Q1, according to the filing. It also reduced its holding in Lululemon Athletica Inc (NASDAQ:LULU) by 12,939 shares in the quarter, leaving it with 125,321 shares, and cut its stake in Ball Corp (NYSE:BLL).
Investors sentiment increased to 1.44 in Q1 2019. Its up 0.51, from 0.93 in 2018Q4. It increased, as 12 investors sold CCXI shares while 27 reduced holdings. 22 funds opened positions while 34 raised stakes. 33.34 million shares or 22.88% more from 27.13 million shares in 2018Q4 were reported. D E Shaw holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 126,359 shares. 30,100 were accumulated by State Of Wisconsin Investment Board. Jpmorgan Chase has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). 14,327 were accumulated by American Interest Group Inc Inc. Zebra Capital Mngmt Llc reported 12,853 shares stake. Moreover, Meeder Asset Management Inc has 0.01% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 6,176 shares. Employees Retirement System Of Texas owns 35,000 shares or 0.01% of their US portfolio. Fosun Limited holds 0.08% or 91,776 shares. Bvf Il holds 2.28% or 1.46M shares. Sio Ltd Liability has invested 1.99% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Sectoral Asset Mgmt accumulated 0.03% or 17,811 shares. Assetmark accumulated 0% or 38 shares. Blackrock has 2.65 million shares. Point72 Asset Management L P, a Connecticut-based fund reported 400,000 shares. Smith Asset Mgmt Group Inc Limited Partnership stated it has 21,617 shares.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.